Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Today's Featured Story The 3 Penny Stocks You Swore You'd Never Buy (But You'll Check Anyway)Written by Chris Markoch. Article Posted: 1/18/2026. 
Key Points - Vaxart is a clinical-stage biotech developing oral vaccines that could transform global immunization if its platform proves effective.
- Microvision develops cost-effective lidar technology for autonomous vehicles, with upside tied to industry adoption and potential partnerships.
- Datavault AI focuses on monetizing digital data through AI and blockchain tools, offering speculative exposure to the emerging data-as-an-asset theme.
Penny stocks attract speculative investors seeking high-risk, high-reward opportunities. Investors typically look for companies with disruptive technologies, exposure to emerging trends, or compelling turnaround stories. Many of these firms will never survive or scale, but a single success can deliver outsized returns. For investors who believe strength lies in numbers, MarketBeat offers a tool that lists the 100 Most Popular Penny Stocks, based on the number of MarketBeat subscribers following each company. While that's no guarantee of success, it can give investors more conviction in a stock's potential. A tiny government task force just wrapped up 20 years of work.
And buried in their federal filings, I found something remarkable:
American citizens now have a legal birthright claim to something previously inaccessible.
Under U.S. law, you can stake your claim right now. The name and ticker are available here now >>> Some define a penny stock as any security trading at $5 or less, but the stocks in this screener follow the traditional definition — shares priced below $1. These securities are highly volatile; conduct your own research and understand your risk tolerance before taking a position. Vaxart: A Potential Game-Changer for Global Immunization Efforts Vaxart Inc. (NASDAQ: VXRT) is a clinical-stage biotechnology company developing oral vaccines for infectious diseases, including influenza, norovirus, and COVID-19. Unlike traditional injectable vaccines, Vaxart's tablet-based platform aims to simplify distribution and improve global accessibility. The bull case centers on that innovative approach. If Vaxart can obtain FDA approval and scale manufacturing, its oral vaccines could reduce logistical barriers to mass immunization and create licensing opportunities. Positive trial data or a commercial collaboration could markedly shift sentiment and valuation from the stock's current low base. Clinical risk is the biggest challenge. Vaxart has not yet brought a product to market, and vaccine development is costly and unpredictable. Competition from established players with larger R&D budgets also constrains visibility. For now, Vaxart is a long-term speculative bet on platform validation rather than near-term profitability. The MarketBeat analyst ratings show only a single analyst covering the stock — not unusual for a microcap, but worth noting. Institutional ownership is about 18%. On the positive side, the stock has roughly 2% short interest, which may temper some volatility. Microvision: Developing Cost-Effective LiDAR Units For Autonomous Driving Microvision Inc. (NASDAQ: MVIS) develops LiDAR (light detection and ranging) sensors used in autonomous vehicles, smart infrastructure, and industrial sensing. Its hardware and software solutions enable precise 3D mapping needed for self-driving and advanced driver-assistance systems (ADAS). Microvision focuses on compact, cost-effective LiDAR units that could appeal to automakers seeking scalable sensor solutions. The bull case rests on two factors: ongoing progress toward vehicle automation and potential partnerships with major automotive manufacturers. If Microvision can demonstrate performance or cost advantages, it could secure supply agreements or licensing deals that materially improve revenue visibility. The technology could also find applications beyond vehicles — in robotics and smart cities — adding optionality to the growth story. Despite the promise, Microvision faces stiff competition from LiDAR companies such as Luminar (NASDAQ: LAZR), Innoviz (NASDAQ: INVZ), and Ouster (NYSE: OUST). The path to profitability is uncertain, and repeated delays in commercial LiDAR adoption have frustrated investors. MVIS is covered by three analysts with a consensus price target of $2.50 — about a 169% increase from its Jan. 15 closing price. Still, like many speculative names, Microvision has relatively low institutional ownership (around 30%) and high short interest (around 21%), meaning investors should expect significant volatility. Datavault AI: Trying to Democratize Data Ownership Datavault AI Inc. (NASDAQ: DVLT) operates at the intersection of artificial intelligence, data monetization, and digital asset management. The company helps organizations convert raw data into tradable, revenue-generating assets through its patented Datavault platform. By combining AI, blockchain, and analytics, Datavault AI aims to democratize data ownership and unlock monetization opportunities that traditional systems overlook. The bullish thesis centers on a niche focus with scalability potential. As data becomes an increasingly valuable commodity, businesses and individuals are seeking ways to safely monetize digital information. Datavault's technology could benefit from broader AI adoption and growing interest in data sovereignty. Early traction or strategic partnerships could catalyze investor confidence. That said, Datavault AI operates in a highly experimental space. Its business model is still evolving, and a path to meaningful revenue growth remains unproven. Institutional ownership is under 1%, and short interest exceeds 16% as of this writing. Investors considering DVLT should view it as a long-term, speculative position based on belief in the "data-as-an-asset" thesis rather than near-term earnings potential.
| 
